Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRSS3 pseudogene 3 (PRSS3P3, TRY3) is a pseudogene in the human genome and does not encode a functional protein. It shares sequence homology with the functional serine protease 3 (PRSS3) gene but lacks protein-coding potential. As a pseudogene, PRSS3P3 is not involved in known biological processes, is not classified in major molecular or therapeutic target families such as enzyme, receptor, transporter, or transcription factor, and is not known to have disease associations or drug interactions. PRSS3P3 is primarily included in gene databases for genome annotation and may be useful for studies on gene evolution and homologous sequences but has no current function or role as a molecular target[4]. Key clarification: PRSS3P3 is distinct from the functional gene PRSS3 (Protease, serine, 3; Trypsin-3/TRY3), which encodes an active serine protease with roles in proteolysis and potential disease significance[1][2][7]. PRSS3P3 itself is a non-functional pseudogene and does not act as a receptor, enzyme, or other typical therapeutic target[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRSS3 pseudogene 3 (PRSS3P3).